Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Why Are Cullinan Oncology Shares Rising Today?

Taiho Pharmaceutical Co Ltd will co-develop and co-commercialize Cullinan Oncology Inc (NASDAQ: CGEM) lead program, CLN-081/TAS6417.

Benzinga

8 Analysts Have This to Say About BRP Group

Within the last quarter, BRP Group (NASDAQ:BRP) has observed the following analyst ratings:

Benzinga

Preview: ProPhase Labs's Earnings

ProPhase Labs (NASDAQ:PRPH) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that ProPhase Labs will report an earnings per share (EPS) of $0.38.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

6 Analysts Have This to Say About FTC Solar

Within the last quarter, FTC Solar (NASDAQ:FTCI) has observed the following analyst ratings:

Benzinga

Recap: InflaRx Q1 Earnings

InflaRx (NASDAQ:IFRX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings InflaRx missed estimated earnings by 5.88%, reporting an EPS of $-0.36 versus an estimate of $-0.34.

Benzinga

Aadi Bioscience: Q1 Earnings Insights

Aadi Bioscience (NASDAQ:AADI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Aadi Bioscience beat estimated earnings by 7.04%, reporting an EPS of $-0.66 versus an estimate of $-0.71.

Benzinga

Lipocine Posts Encouraging Data For Testosterone Prodrug In NASH Patients

Lipocine Inc (NASDAQ:LPCN) has announced topline results from its Open-Label Extension (OLE) study of LPCN 1144, including an orally delivered prodrug of testosterone. Twenty-five subjects were enrolled, of whom 16 subjects from the LiFT study continued LPCN 1144 treatment for additional 36 weeks (total of 72 weeks), and nine subjects initiated LPCN 1144…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Overview Of Value Stocks In The Financial Services Sector

What Defines a Value Stock?

Benzinga

Ominous Death Cross Forms On JB Hunt Transport Servs's Chart

If history is any guide, there may be trouble ahead for shares of JB Hunt Transport Servs (NASDAQ:JBHT). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

A Bearish Sign Appears On Fox's Chart

If history is any guide, there may be trouble ahead for shares of Fox (NASDAQ:FOXA). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Falcon Minerals: Dividend Insights

Monday marks the last chance for investors to receive the next dividend payout from Falcon Minerals (NASDAQ:FLMN).

Benzinga

Wells Fargo Upgrades ON Semiconductor On EV Prospects

ON Semiconductor Corp (NASDAQ: ON) has the opportunity to become one of the leading suppliers of silicon carbide (SiC) power devices to the electric vehicle market, according to Wells Fargo.

Benzinga

Read How Himax Technologies Fared In Q1

Himax Technologies, Inc (NASDAQ:HIMX) reported first-quarter FY22 revenue growth of 33.6% year-on-year to $412.8 million. Net revenues declined 8.6% sequentially. Revenue from large display drivers grew 60% Y/Y to $110.6 million. Monitor and notebook IC sales decreased sequentially on the backdrop of slowing end market sell-through. TV revenue was flat sequentially, anchored by…

Benzinga

Why Apple Stock Will Bounce Despite Bear Cycle

Apple, Inc (NASDAQ: AAPL) gapped down about 2.4% to start Thursday’s trading session and within the first few minutes had fallen 4% off Wednesday’s closing price.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

CASI Pharmaceuticals: Q1 Earnings Insights

CASI Pharmaceuticals (NASDAQ:CASI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Aemetis Q1 Earnings

Aemetis (NASDAQ:AMTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Aemetis missed estimated earnings by 42.11%, reporting an EPS of $-0.54 versus an estimate of $-0.38.

Benzinga

IMV Earnings Preview

IMV (NASDAQ:IMV) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that IMV will report an earnings per share (EPS) of $-0.13.

Benzinga

Expert Ratings for Kinetik Holdings

Analysts have provided the following ratings for Kinetik Holdings (NASDAQ:KNTK) within the last quarter:

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Earnings Preview: ReWalk Robotics

ReWalk Robotics (NASDAQ:RWLK) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that ReWalk Robotics will report an earnings per share (EPS) of $-0.05.

Benzinga

Longeveron's Earnings: A Preview

Longeveron (NASDAQ:LGVN) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that Longeveron will report an earnings per share (EPS) of $-0.22.

Benzinga

Earnings Preview For Honest Co

Honest Co (NASDAQ:HNST) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that Honest Co will report an earnings per share (EPS) of $-0.15.

Benzinga

A Preview Of PLx Pharma's Earnings

PLx Pharma (NASDAQ:PLXP) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that PLx Pharma will report an earnings per share (EPS) of $-0.72.

Benzinga

Analyst Ratings for Wendy's

Over the past 3 months, 10 analysts have published their opinion on Wendy's (NASDAQ:WEN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

What 4 Analyst Ratings Have To Say About Allakos

Allakos (NASDAQ:ALLK) has observed the following analyst ratings within the last quarter:

Benzinga

Where Olaplex Hldgs Stands With Analysts

Over the past 3 months, 6 analysts have published their opinion on Olaplex Hldgs (NASDAQ:OLPX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

1 … 499 500 501 502

People

Gary Mobley

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

JB Hunt Transport Servs

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.